Why the study?
Clinical trials of remimazolam did not include patients complicated with severe heart failure or undergoing cardiac surgery.
Does remimazolam provide safe anesthetic management with minimal cardiovascular depression in a patient with advanced heart failure undergoing MitraClip implantation?
Comparison
Remimazolam for anesthetic induction and maintenance followed by flumazenil
Design
Case report
Authors
Loading...
Hypothesis-generating for remimazolam in advanced HF; should not yet change practice pending prospective trials.
Does remimazolam provide safe anesthetic management with minimal cardiovascular depression in a patient with advanced heart failure undergoing MitraClip implantation?
Remimazolam may be a safe and effective anesthetic agent for patients with severe cardiovascular diseases undergoing structural heart interventions.
Satoh et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: